Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial. - Horwitz SM; Nirmal AJ; Rahman J; Xu R; Drill E; Galasso N; Ganesan N; Davey T; Hancock H; Perez L; Maccaro C; Bahgat A; et al. (Nature medicine, 2024)